Maarten Persenaire
CIK 1207313 · View on SEC EDGAR ↗
First SEC filing: Nov. 7, 2019 · Latest: Nov. 7, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2021 | TELA | A | 21,800 | — | — | 21,800 Direct | — | Acquired | (price as of 2026-08-20) |
| Feb. 24, 2021 | TELA | A | 12,000 | — | — | 90,887 Direct | +15.21% | Acquired | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 12,931 | — | — | 12,931 Direct | — | Acquired | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 12,931 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 315,086 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 197,511 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 12,760 | — | — | 78,887 Direct | +19.30% | Acquired | (price as of 2026-08-20) |
| Nov. 13, 2019 | TELA | C | 7,999 | — | — | 66,127 Direct | +13.76% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 24, 2021 | TELA | Stock Option (right to buy) | Common Stock (21,800) | $16.99 | Feb. 24, 2031 | 21,800 | Acquired |
| Nov. 13, 2019 | TELA | Warrant (right to buy) | Series B Preferred Stock (523) | $28.65 | Jan. 18, 2027 | 12,931 | Acquired |
| Nov. 13, 2019 | TELA | Warrant (right to buy) | Series B Preferred Stock (12,931) | $1.16 | Jan. 18, 2027 | 12,931 | Disposed |
| Nov. 13, 2019 | TELA | Series B Preferred Stock | Common Stock | — | — | 315,086 | Disposed |
| Nov. 13, 2019 | TELA | Series A Preferred Stock | Common Stock | — | — | 197,511 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 7, 2019 | TELA | Common Stock | 42,556 | Direct |
| Nov. 7, 2019 | TELA | Series A Preferred Stock→ Common Stock (197,511) | 197,511 | Direct |
| Nov. 7, 2019 | TELA | Series B Preferred Stock→ Common Stock (12,760) | 12,760 | Direct |
| Nov. 7, 2019 | TELA | Warrant→ Series B Preferred Stock (12,931) | 12,931 | Direct |
| Nov. 7, 2019 | TELA | Employee Stock Option (right to buy)→ Common Stock (10,592) | 10,592 | Direct |
| Nov. 7, 2019 | TELA | Employee Stock Option (right to buy)→ Common Stock (10,241) | 10,241 | Direct |
| Nov. 7, 2019 | TELA | Stock Option (right to buy)→ Common Stock (70,879) | 70,879 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
TELA
M.D. Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $346,750 | — | — | — | $180,500 | — | $3,000 | $530,250 |
| 2018 | $280,000 | — | — | $7,510 | $122,500 | — | — | $410,010 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.